Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin in Hemodynamically Stable Patients with Worsening Heart Failure
NCT03292653Phase 2Terminated
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Dec 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sotagliflozin in heart failure (HF), sponsored by Lexicon Pharmaceuticals, Inc.. Started Dec 2017; status: terminated.
02
Drugs
sotagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03292653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03292653.